UNSPSC 51241709: Edta/thimerosal

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OP400. This VA Drug Class (OP400) classifies this compound as belonging to the group CONTACT LENS SOLUTIONS.

UNSPSC 51241709 Edta/thimerosal is a Commodity code covering chemical preservatives and pharmaceutical additives used in vaccines, biologics, and injectable medications. State and local governments procure these compounds primarily through cooperative purchasing vehicles that aggregate demand across multiple jurisdictions and healthcare facilities. The work involves supplying FDA-compliant pharmaceutical-grade chemicals with full chain-of-custody documentation, cGMP certification, and compliance with the Drug Supply Chain Security Act (DSCSA). Issuing bodies include state departments of health and administration, multistate cooperative purchasing alliances, and public healthcare systems. Procurement is heavily structured around authorized wholesale distributors and electronic data interchange (EDI) systems, requiring vendors to maintain pricing flexibility across flat-price and net-price formats and to document National Drug Codes (NDCs), strength, dosage forms, and manufacturing locations for each product.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP in January 2026 to establish multiple contracts for generic multi-source pharmaceuticals and OTC products (Solicitation S1070000015802, due March 26, 2026). The contract spans participating state and local government facilities including Minnesota and Oregon, with awarded vendors required to maintain relationships with at least two of three authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC) and to pay a 3 percent administrative fee on all purchases. Products must be available by May 15, 2026 and agreements become effective July 1, 2026. Evaluation emphasizes price competitiveness (75 percent weight), with 10 percent on fixed pricing, 5 percent each on administrative compliance and EDI capability. Vendors must carry commercial general liability insurance of $5,000,000 per occurrence and maintain minimum six-month shelf life on all products.